Effect of sitagliptin on blood glucose control in patients with type 2 diabetes mellitus who are treatment naive or poorly responsive to existing antidiabetic drugs: the JAMP study

BACKGROUND: To investigate the ameliorating effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on blood glucose control in patients with type 2 diabetes mellitus who were previously untreated with or who have a poor responsive to existing antidiabetic drugs. METHODS: Sitagliptin (50 mg/day)...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakura, Hiroshi, Hashimoto, Naotake, Sasamoto, Kazuo, Ohashi, Hiroshi, Hasumi, Sumiko, Ujihara, Noriko, Kasahara, Tadasu, Tomonaga, Osamu, Nunome, Hideo, Honda, Masashi, Iwamoto, Yasuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133763/
https://www.ncbi.nlm.nih.gov/pubmed/27905912
http://dx.doi.org/10.1186/s12902-016-0149-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133763/
https://www.ncbi.nlm.nih.gov/pubmed/27905912
http://dx.doi.org/10.1186/s12902-016-0149-z

Ejemplares similares